Press Releases
Samsung Biologics receives the Terra Carta Seal in recognition...
Samsung Biologics, a leading contract development and manufacturing organization (CDMO), was awarded the Sustainable Markets Initiative’s Terra Carta Seal.
The Terra Carta Seal, launched at COP26...
Press Releases
Phastar enhances Data Visualization and Analytics solution through acquisition...
Phastar announced the acquisition of S-Cubed ApS, a specialist biometrics and data visualization company. The deal takes the PHASTAR group to around 550 people worldwide...
Drug Research
AbbVie and Immunome Announce Strategic Collaboration to Discover Multiple...
AbbVie and Immunome, Inc., a clinical-stage biopharmaceutical company that utilizes its human memory B cell platform to discover and develop first-in-class antibody therapeutics, announced a...
Drug Research
CytomX and Moderna Announce Strategic Research Collaboration for mRNA-Based...
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and CytomX Therapeutics, Inc., a leader in the field of conditionally activated oncology...
Drug Research
WuXi Biologics and GSK Enter into License Agreement on...
WuXi Biologics , a leading global Contract Research, Development, and Manufacturing Organization announced a license agreement with GSK plc under which GSK will have exclusive...
Press Releases
TMC Pharma Appoints Industry Veteran To Board
TMC Pharma Services, an international Pharmaceutical Development Organisation specialising in Orphan Drug development, has appointed Gordon Cameron as a Non-Executive Director to support the growth...
Press Releases
Hetero’s ‘NIRMACOM’ is world’s first generic version of COVID-19...
Hetero, India’s leading pharmaceutical company with the widest global reach, announced the receipt of World Health Organization Prequalification of Medicines Program (WHO PQ) approval for...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.